Magnetar Financial’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-10,308
Closed -$1.28M – 1384
2021
Q2
$1.28M Buy
+10,308
New +$1.39M 0.01% 664
2020
Q3
– Sell
-10,305
Closed -$836K – 679
2020
Q2
$836K Buy
+10,305
New +$830K 0.02% 215
2020
Q1
– Sell
-7,632
Closed -$596K – 537
2019
Q4
$596K Sell
7,632
-4,698
-38% -$339K 0.01% 279
2019
Q3
$787K Buy
12,330
+7,330
+147% +$646K 0.02% 280
2019
Q2
$432K Buy
+5,000
New +$382K 0.01% 319
2019
Q1
– Sell
-20,600
Closed -$774K – 437
2018
Q4
$774K Buy
+20,600
New +$759K 0.02% 130

Other funds holding GH

Magnetar Financial's GH Position: Q3 2021 in Review

Magnetar Financial sold out of Guardant Health (GH) in Q3 2021, closing a stake of 10,308 shares — an estimated $1.28M sold.

Magnetar Financial first reported a position in GH in Q4 2018 and held it in 6 quarters. The position peaked at $1.28M in Q2 2021. 374 funds tracked by Wall St. Rank hold GH as of Q3 2021.

  • Magnetar Financial reported no remaining Guardant Health position as of Q3 2021 after selling out during the quarter.
  • Magnetar Financial sold 10,308 Guardant Health shares in Q3 2021, an estimated $1.28M.
  • Magnetar Financial first reported a position in Guardant Health in Q4 2018 and held it in 6 quarters.
  • Magnetar Financial's Guardant Health position peaked at $1.28M in Q2 2021.
  • 374 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on Magnetar Financial's 13F filing for Q3 2021, filed 12 Nov 2021.